← All drugs Report issue

sc-80036

Small moleculeexperimental

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Mechanism of action

MAP kinase p38 alphaINHIBITOR
MAPK14 inhibitor
- Mitogen-activated protein kinase 14 (MAPK14) ↗

Chemistry & pharmacology

Chirality: Single Stereoisomer
Inorganic: No
Polymer: No

Oral

No

Parenteral

No

Topical

No

Sources

ChEMBLCHEMBL3544930 ↗

Also known as

sc-80036